Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group

T. R. Rebbeck, T. Friebel, H. T. Lynch, S. L. Neuhausen, L. van't Veer, J. E. Garber, G. R. Evans, S. A. Narod, C. Isaacs, E. Matloff, M. B. Daly, O. I. Olapade, B. L. Weber, Gary N. Mann

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)241-242
Number of pages2
JournalWomen's Oncology Review
Volume4
Issue number3
DOIs
StatePublished - Sep 1 2004

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynecology
  • Cancer Research

Cite this

Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van't Veer, L., Garber, J. E., Evans, G. R., Narod, S. A., Isaacs, C., Matloff, E., Daly, M. B., Olapade, O. I., Weber, B. L., & Mann, G. N. (2004). Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group. Women's Oncology Review, 4(3), 241-242. https://doi.org/10.1080/14733400400013030